MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
Hutchison China MediTech Limited Total Inventories 2011-2026 | HCM
Annual Total Inventories Hutchison China MediTech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.1 M | 50.4 M | 50.3 M | 56.7 M | 35.8 M | 19.8 M | 16.2 M | 12.3 M | 11.8 M | 12.8 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 56.7 M | 11.8 M | 30.7 M |
Quarterly Total Inventories Hutchison China MediTech Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 35.8 M | - | 25.5 M | - | 19.8 M | - | 15.3 M | - | 16.2 M | 15.7 M | 14.2 M | 17.6 M | 12.3 M | - | 9.79 M | - | 11.8 M | - | 10.7 M | - | 12.8 M | - | - | - | 9.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 35.8 M | 9.56 M | 16.2 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.66 | 1.14 % | $ 1.01 B |  USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.9 | -0.2 % | $ 6.62 M |  China |
 |
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.33 | 1.66 % | $ 3.7 B | USA |
 |
Esperion Therapeutics
ESPR
|
105 M | $ 1.94 | 1.31 % | $ 403 M | USA |
 |
Heron Therapeutics
HRTX
|
92.7 M | $ 1.18 | -0.84 % | $ 197 M | USA |
 |
ImmuCell Corporation
ICCC
|
9.27 M | $ 8.26 | -1.07 % | $ 74.6 M | USA |
 |
Jaguar Health
JAGX
|
8.6 M | $ 0.29 | -25.25 % | $ 676 K | USA |
 |
KalVista Pharmaceuticals
KALV
|
3.43 M | $ 19.09 | -2.75 % | $ 1.03 B |  Britain |
 |
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.11 | 0.61 % | $ 439 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.18 | -0.34 % | $ 2.95 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.43 | -0.7 % | $ 381 M | Britain |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
14.1 M | $ 240.72 | 4.09 % | $ 4.4 B | USA |
 |
Eli Lilly and Company
LLY
|
13.7 B | $ 874.81 | -1.06 % | $ 785 B | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |